HEADER HYDROLASE/HYDROLASE INHIBITOR 04-MAY-17 5VP9 TITLE CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH AM-07, AN TITLE 2 ANALOGUE OF 5172-MCP1P3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NS4A COFACTOR -- NS3 PROTEIN CHIMERA; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS SUBTYPE 1A; SOURCE 3 ORGANISM_TAXID: 31646; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) MAGIC; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS NS3/4A PROTEASE, HEPATITIS C VIRUS, DRUG RESISTANCE, PROTEASE KEYWDS 2 INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.N.MATTHEW,C.A.SCHIFFER REVDAT 3 04-OCT-23 5VP9 1 REMARK REVDAT 2 26-JUL-17 5VP9 1 JRNL REVDAT 1 21-JUN-17 5VP9 0 JRNL AUTH A.N.MATTHEW,J.ZEPHYR,C.J.HILL,M.JAHANGIR,A.NEWTON, JRNL AUTH 2 C.J.PETROPOULOS,W.HUANG,N.KURT-YILMAZ,C.A.SCHIFFER,A.ALI JRNL TITL HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS INCORPORATING JRNL TITL 2 FLEXIBLE P2 QUINOXALINES TARGET DRUG RESISTANT VIRAL JRNL TITL 3 VARIANTS. JRNL REF J. MED. CHEM. V. 60 5699 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28594175 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00426 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 16794 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 20.9886 - 3.3744 1.00 2794 149 0.1654 0.2142 REMARK 3 2 3.3744 - 2.6801 1.00 2676 145 0.1747 0.2077 REMARK 3 3 2.6801 - 2.3418 1.00 2644 132 0.1668 0.2060 REMARK 3 4 2.3418 - 2.1280 1.00 2651 137 0.1549 0.1817 REMARK 3 5 2.1280 - 1.9756 1.00 2616 139 0.1609 0.1953 REMARK 3 6 1.9756 - 1.8592 0.99 2569 142 0.1952 0.2475 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1553 REMARK 3 ANGLE : 0.885 2118 REMARK 3 CHIRALITY : 0.054 243 REMARK 3 PLANARITY : 0.005 269 REMARK 3 DIHEDRAL : 12.726 918 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VP9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1000227774. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16852 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.859 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 15.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5EPN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES BUFFER PH 6.5, 4% (W/V) REMARK 280 AMMONIUM SULFATE, 20-26% PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.39600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.21050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.17750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.21050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.39600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.17750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 980 REMARK 465 SER A 981 REMARK 465 HIS A 982 REMARK 465 SER A 1181 REMARK 465 PRO A 1182 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A1003 CG OD1 OD2 REMARK 470 GLN A1021 CG CD OE1 NE2 REMARK 470 ARG A1092 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1400 O HOH A 1436 1.94 REMARK 500 O HOH A 1426 O HOH A 1435 1.94 REMARK 500 O HOH A 1307 O HOH A 1433 2.02 REMARK 500 O HOH A 1424 O HOH A 1439 2.06 REMARK 500 O HOH A 1436 O HOH A 1457 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 1013 NH2 ARG A 1180 3545 2.18 REMARK 500 O HOH A 1301 O HOH A 1419 4445 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1043 -164.71 -160.78 REMARK 500 MET A1179 6.27 -69.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1203 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1097 SG REMARK 620 2 CYS A1099 SG 108.3 REMARK 620 3 CYS A1145 SG 111.4 120.3 REMARK 620 4 HIS A1149 ND1 124.8 96.0 96.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9H7 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 1203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5VOJ RELATED DB: PDB DBREF 5VP9 A 990 1000 UNP A8DG50 A8DG50_9HEPC 1678 1688 DBREF 5VP9 A 1003 1182 UNP A8DG50 A8DG50_9HEPC 1029 1208 SEQADV 5VP9 GLY A 980 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 SER A 981 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 HIS A 982 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 MET A 983 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 ALA A 984 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 SER A 985 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 MET A 986 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 LYS A 987 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 LYS A 988 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 LYS A 989 UNP A8DG50 EXPRESSION TAG SEQADV 5VP9 SER A 991 UNP A8DG50 CYS 1679 ENGINEERED MUTATION SEQADV 5VP9 ILE A 998 UNP A8DG50 VAL 1686 ENGINEERED MUTATION SEQADV 5VP9 ASN A 999 UNP A8DG50 ILE 1687 ENGINEERED MUTATION SEQADV 5VP9 SER A 1001 UNP A8DG50 LINKER SEQADV 5VP9 GLY A 1002 UNP A8DG50 LINKER SEQADV 5VP9 ASP A 1003 UNP A8DG50 ILE 1029 ENGINEERED MUTATION SEQADV 5VP9 GLU A 1013 UNP A8DG50 LEU 1039 ENGINEERED MUTATION SEQADV 5VP9 GLU A 1014 UNP A8DG50 LEU 1040 ENGINEERED MUTATION SEQADV 5VP9 GLN A 1017 UNP A8DG50 ILE 1043 ENGINEERED MUTATION SEQADV 5VP9 GLU A 1018 UNP A8DG50 ILE 1044 ENGINEERED MUTATION SEQADV 5VP9 GLN A 1021 UNP A8DG50 LEU 1047 ENGINEERED MUTATION SEQADV 5VP9 THR A 1040 UNP A8DG50 ALA 1066 ENGINEERED MUTATION SEQADV 5VP9 SER A 1047 UNP A8DG50 CYS 1073 ENGINEERED MUTATION SEQADV 5VP9 LEU A 1052 UNP A8DG50 CYS 1078 ENGINEERED MUTATION SEQADV 5VP9 THR A 1072 UNP A8DG50 ILE 1098 ENGINEERED MUTATION SEQADV 5VP9 GLN A 1086 UNP A8DG50 PRO 1112 ENGINEERED MUTATION SEQADV 5VP9 SER A 1159 UNP A8DG50 CYS 1185 ENGINEERED MUTATION SEQRES 1 A 203 GLY SER HIS MET ALA SER MET LYS LYS LYS GLY SER VAL SEQRES 2 A 203 VAL ILE VAL GLY ARG ILE ASN LEU SER GLY ASP THR ALA SEQRES 3 A 203 TYR ALA GLN GLN THR ARG GLY GLU GLU GLY CYS GLN GLU SEQRES 4 A 203 THR SER GLN THR GLY ARG ASP LYS ASN GLN VAL GLU GLY SEQRES 5 A 203 GLU VAL GLN ILE VAL SER THR ALA THR GLN THR PHE LEU SEQRES 6 A 203 ALA THR SER ILE ASN GLY VAL LEU TRP THR VAL TYR HIS SEQRES 7 A 203 GLY ALA GLY THR ARG THR ILE ALA SER PRO LYS GLY PRO SEQRES 8 A 203 VAL THR GLN MET TYR THR ASN VAL ASP LYS ASP LEU VAL SEQRES 9 A 203 GLY TRP GLN ALA PRO GLN GLY SER ARG SER LEU THR PRO SEQRES 10 A 203 CYS THR CYS GLY SER SER ASP LEU TYR LEU VAL THR ARG SEQRES 11 A 203 HIS ALA ASP VAL ILE PRO VAL ARG ARG ARG GLY ASP SER SEQRES 12 A 203 ARG GLY SER LEU LEU SER PRO ARG PRO ILE SER TYR LEU SEQRES 13 A 203 LYS GLY SER SER GLY GLY PRO LEU LEU CYS PRO ALA GLY SEQRES 14 A 203 HIS ALA VAL GLY ILE PHE ARG ALA ALA VAL SER THR ARG SEQRES 15 A 203 GLY VAL ALA LYS ALA VAL ASP PHE ILE PRO VAL GLU SER SEQRES 16 A 203 LEU GLU THR THR MET ARG SER PRO HET 9H7 A1201 99 HET SO4 A1202 5 HET ZN A1203 1 HETNAM 9H7 TERT-BUTYL [(2R,6S,12Z,13AS,14AR,16AS)-14A- HETNAM 2 9H7 [(CYCLOPROPYLSULFONYL)CARBAMOYL]-5,16-DIOXO-2-{[3- HETNAM 3 9H7 (THIOPHEN-2-YL)QUINOXALIN-2-YL]OXY}-1,2,3,5,6,7,8,9, HETNAM 4 9H7 10,11,13A,14,14A,15,16,16A- HETNAM 5 9H7 HEXADECAHYDROCYCLOPROPA[E]PYRROLO[1,2-A][1, HETNAM 6 9H7 4]DIAZACYCLOPENTADECIN-6-YL]CARBAMATE HETNAM SO4 SULFATE ION HETNAM ZN ZINC ION FORMUL 2 9H7 C38 H46 N6 O8 S2 FORMUL 3 SO4 O4 S 2- FORMUL 4 ZN ZN 2+ FORMUL 5 HOH *157(H2 O) HELIX 1 AA1 GLY A 1012 GLY A 1023 1 12 HELIX 2 AA2 VAL A 1055 GLY A 1060 1 6 HELIX 3 AA3 SER A 1133 LEU A 1135 5 3 HELIX 4 AA4 VAL A 1172 MET A 1179 1 8 SHEET 1 AA1 7 TYR A1006 GLN A1009 0 SHEET 2 AA1 7 VAL A 993 ASN A 999 -1 N ASN A 999 O TYR A1006 SHEET 3 AA1 7 VAL A1033 SER A1037 -1 O ILE A1035 N VAL A 995 SHEET 4 AA1 7 THR A1042 ILE A1048 -1 O ALA A1045 N GLN A1034 SHEET 5 AA1 7 VAL A1051 THR A1054 -1 O TRP A1053 N THR A1046 SHEET 6 AA1 7 LEU A1082 GLN A1086 -1 O TRP A1085 N LEU A1052 SHEET 7 AA1 7 TYR A1075 ASN A1077 -1 N ASN A1077 O LEU A1082 SHEET 1 AA2 7 ASP A1103 VAL A1107 0 SHEET 2 AA2 7 VAL A1113 ARG A1118 -1 O ILE A1114 N LEU A1106 SHEET 3 AA2 7 ARG A1123 PRO A1131 -1 O SER A1125 N ARG A1117 SHEET 4 AA2 7 VAL A1163 PRO A1171 -1 O ALA A1164 N ARG A1130 SHEET 5 AA2 7 ALA A1150 THR A1160 -1 N ALA A1156 O ASP A1168 SHEET 6 AA2 7 PRO A1142 LEU A1144 -1 N LEU A1143 O VAL A1151 SHEET 7 AA2 7 ASP A1103 VAL A1107 -1 N TYR A1105 O LEU A1144 LINK SG CYS A1097 ZN ZN A1203 1555 1555 2.31 LINK SG CYS A1099 ZN ZN A1203 1555 1555 2.41 LINK SG CYS A1145 ZN ZN A1203 1555 1555 2.25 LINK ND1 HIS A1149 ZN ZN A1203 1555 1555 2.16 SITE 1 AC1 21 GLN A1041 PHE A1043 TYR A1056 HIS A1057 SITE 2 AC1 21 GLY A1058 ASP A1081 ARG A1123 LEU A1135 SITE 3 AC1 21 LYS A1136 GLY A1137 SER A1138 SER A1139 SITE 4 AC1 21 PHE A1154 ARG A1155 ALA A1156 ALA A1157 SITE 5 AC1 21 ASP A1168 SO4 A1202 HOH A1312 HOH A1380 SITE 6 AC1 21 HOH A1385 SITE 1 AC2 8 TYR A1006 GLN A1008 TYR A1056 9H7 A1201 SITE 2 AC2 8 HOH A1312 HOH A1353 HOH A1354 HOH A1382 SITE 1 AC3 4 CYS A1097 CYS A1099 CYS A1145 HIS A1149 CRYST1 54.792 58.355 60.421 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018251 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017136 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016551 0.00000